Close Menu

NEW YORK – Waters reported before the opening of the market on Tuesday that its second quarter revenues were flat year over year, though the company noted that it expects new product introductions and improving end markets will drive growth in the second half of 2019.

For the three months ended June 29, the company posted Q2 revenues of $599.2 million, up less than 1 percent from $596.2 million in Q2 2018, and short of the average Wall Street estimate of $601.4 million. Foreign currency translation depressed revenues by 2 percent, the company said.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

The Wall Street Journal looks into FamilyTreeDNA's handling of genetic genealogy searches by law enforcement.

In a point-counterpoint in the Boston Globe, researchers discuss the potential of gene editing to prevent Lyme disease, but also the pitfalls of doing so.

MIT's Technology Review reports that researchers hope to develop a CRISPR-based pain therapy.

In Science this week: atlas of malaria parasites' gene expression across their life cycles, and more.

Oct
23
Sponsored by
Swift Biosciences

This webinar will illustrate how single-cell methylation sequencing can be applied to gain significant insight into epigenetic heterogeneity in disease states, advancing cancer research discoveries.